← Back
$CAMP All transactions

Camp4 Therapeutics Corp

▲ BUY
9 / 10

Conviction

$ Value

$4.5M

Shares

2,941,176

Price

$2

Filed

Sep 15

Why this score? (9/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • 10%+ owner (+1)
  • Cluster: 7 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

5AM Partners VI, LLC

Title

CIK

0001829051

Roles

10% Owner

Transaction Details

Transaction Date

2025-09-11

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,941,176

Footnotes

The shares are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports. | The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports. | The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II. Each of Opportunities II GP and Dr. Parmar disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.

Filing Info

Accession No.

0001231919-25-000196

Form Type

4

Issuer CIK

0001736730

5AM Partners VI, LLC's History

Date Ticker Type Value
2025-09-11 CAMP $4.5M

Other Insiders at CAMP (90d)

Insider Bought Sold Last
MacLean Michael F 2026-04-01
Maricich Yuri
Chief Medical Officer
2026-04-01
Mandel-Brehm Josh
Chief Executive Officer
2026-04-01
Gold Kelly
Chief Financial Officer
2026-04-01
Tardiff Daniel
Chief Scientific Officer
2026-04-01